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M6a is expressed in the murine neural retina and regulates neurite
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Purpose: Glycoprotein m6a (M6a) is a cell-surface glycoprotein that belongs to the myelin proteolipid protein family.
M6a is expressed mainly in the nervous system, and its expression and function in mammalian retina have not been
described. Using proteomics analysis of mouse retinal membrane fractions, we identified M6a as a retinal membrane
protein that is strongly expressed at embryonic stages. Our aim was to reveal the function of M6a in development of mouse
retina in this work.
Methods: Detailed expression pattern of M6a was examined by immunostaining using frozen sections of mouse retina
obtained at various developmental stages. For functional analysis of M6a in mouse retinal development, we performed
retorovirus-mediated overexpression of M6a in mouse retinal explant culture. Then, cell differentiation, proliferation and
structural maturation of the cells were examined.
Results: M6a transcripts were strongly expressed in embryonic retina. After completion of retinal differentiation, the level
of expression decreased as mouse development progressed. Immunohistochemistry showed that in the immature mouse
retina, M6a was strongly expressed in the axons of retinal ganglion cells. After birth, M6a expression was confined to the
inner plexiform layer, and finally, to the inner and outer plexiform layers of adult mouse retina. M6a expression was
completely paralleled by that of the synaptic marker, synaptophysin. Mouse retinal progenitor cells that overexpressed
M6a following retrovirus-mediated gene transfer were subjected to in vitro explant or monolayer cultures. The neurite
outgrowth of M6a-overexpressing retinal cells was strikingly enhanced, although M6a did not affect differentiation and
proliferation.
Conclusions: These results suggest that M6a plays a role in retinal development by regulating neurites, and it may also
function to modulate synaptic activities in the adult retina.
The mature neural retina is organized into a three-layered
structure consisting of Müller glia, astrocytes, and six types
of  neurons.  These  cells  are  assumed  to  differentiate  in  a
precise  histogenic  order  from  a  single  population  of
multipotent retinal precursors [1]. Various molecules, such as
transcription  factors  and  neurotrophic  factors,  have  been
reported to play important roles in retinal cell differentiation
[2].  However,  the  intrinsic  properties  of  retinal  cells  at
different developmental stages are still vague. This is in part
due to the lack of markers that can identify distinct stages of
retinal progenitor cells. In our previous studies, we have tried
to identify markers of retinal progenitor cells by employing
flow cytometry and cell sorting. Using a panel of antibodies
against cell-surface antigens, we screened mouse retinal cells
at various developmental stages for reactivity. This technique
obtained unique expression patterns for more than 30 antigens
in the developing retina. Among them, some CD antigens,
such as SSEA-1 (CD15) and c-kit (CD117) were identified as
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retinal progenitor cell markers in early and late immature
stages, respectively [3,4].
Since this approach only identifies known molecules, we
used proteomics to examine the comprehensive expression
profile of total membrane proteins from embryonic and adult
mouse retina. Information about membrane proteins, which
are expressed in a specific manner in the developing retina,
may  not  only  serve  as  a  tool  for  purification  of  retinal
subfractions  by  cell  sorting,  but  may  also  be  useful  for
analyzing the regulation of retinal development by receptor-
signaling  and  cell  surface  molecules.  To  establish  such  a
database, we used shotgun analysis and a nanoflow liquid
chromatography-mass spectrometry/ mass spectrometry (LC-
MS/MS)  system  to  examine  total  protein  expression  in
purified  membrane  fractions  [5].  We  identified  several
membrane-associated  proteins  which  are  expressed  in
embryonic retina [5], and among the proteins, we focused on
glycoprotein m6a (M6a) in this work.
M6a  is  a  transmembrane  protein  that  belongs  to  the
myelin  proteolipid  protein  (PLP)  family.  The  M6a  gene
encodes a 278 amino acid protein that contains four putative
transmembrane  domains  with  both  the  N-  and  C-termini
facing the cytosol. PLP constitutes the most abundant protein
(approximately 50%) in the central nervous system (CNS)
myelin sheath and is involved in signaling through integrins
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1623in oligodendrocytes [6]. Although PLP and its splice variant
DM20 are glial proteins, M6a is found exclusively in neurons
[7].  M6a  is  present  on  the  postmitotic  neurons  of  the
developing  neural  tube  at  embryonic  day  9  (E9)  and  is
continuously expressed in multiple regions of the CNS in the
mouse. Furthermore, the M6a protein is located at the leading
edge of the growth cone in cultured cerebellar neurons [8].
Recent studies have suggested the importance of M6a in the
process of neural development, such as neurite extension,
survival [9], and differentiation [10]. Furthermore, M6a has
been found to play an important role in neurite outgrowth and
filopodium and spine formation, and may also be involved in
synapse formation in cultured hippocampal cells [11]. These
findings indicate the possible involvement of M6a in neuronal
survival and differentiation. However, the expression pattern
and  function  of  M6a  in  the  mouse  retina  have  not  been
investigated to date.
We  identify  M6a  as  a  gene  that  is  expressed  in  the
embryonic retina and reveal the expression patterns of M6a in
the neural processes, including the nerve fiber layer (NFL),
inner plexiform layer (IPL), and outer plexiform layer (OPL),
of  the  immature  mouse  retina.  We  also  show  that  the
expression of M6a parallels that of synaptophysin. Forced
expression of M6a in mouse retinal explant cultures resulted
in enhancement of neurite extension, which suggests that M6a
plays  important  roles  in  the  regulation  of  neurites  in  the
embryonic retina.
METHODS
Isolation of retina from mice: ICR mice were obtained from
Japan SLC, Inc. (Hamamatsu, Japan) and Clea Japan, Inc.
(Tokyo,  Japan).  Mice  are  housed  under  12/12  light/dark
cycles in standard shoebox cages with water and food at 23°C.
The day that a vaginal plug was observed was considered to
be embryonic day 0 (E0), and the day of birth was marked as
postnatal day 0 (P0). All animal experiments were approved
by the Animal Care Committee of the Institute of Medical
Science,  University  of  Tokyo.  Mice  were  euthanized  by
decapitation or cervical dislocation under anesthesia.
Plasmid  construction  and  production  of  retrovirus:  The
mouse  M6a  cDNA  was  cloned  by  RT–PCR  from  pooled
mouse cDNA from P1 retina. The primers were designed
based on the sequences available in the database. A full-length
fragment of M6a was cloned into the Not I site of the pMXc-
IRES-EGFP  retrovirus  vector  (kindly  provided  by  Dr.  T.
Kitamura,  University  of  Tokyo,  Japan),  which  directs
expression of the cloned genes together with enhanced green
fluorescent  protein  (EGFP)  from  upstream  long  terminal
repeat  (LTR)  promoter.  Production  of  the  retrovirus  was
performed  using  the  PLAT-E  packaging  cell  line  [12]  as
previously described [13]. Briefly, PLAT-E was transfected
with retrovirus vectors containing various genes by using
Fugene6  transfection  reagent  (Roche,  Indianapolis,  IN)
according to the manufacturer’s instructions. Two days after
transfection,  cell  supernatants  containing  retrovirus  were
harvested and concentrated by centrifugation in a centrifugal
filter device (Millipore, Billerica, MA).
RT–PCR: Total RNA was purified from mouse retinas by use
of Trizol reagent (Gibco BRL, Carlsbad, CA), and cDNA was
synthesized with Superscript II (Gibco BRL). The primer sets
were tested for several different cycling numbers by using
rTaq (Takara, Otsu, Japan), and the semiquantitative cycle
number  was  determined  for  each  primer  set.  Bands  were
visualized with ethidium bromide.
Retinal explant culture, retrovirus infection, and monolayer
culture:  Retinal  explants  were  prepared  as  previously
described [13]. Briefly, the neural retina was isolated on a
Millicell chamber filter and placed with the ganglion cell layer
facing upwards. The filters were inserted into six-well plates
and cultured in 1 ml of explant culture medium (50% MEM
with Hepes, 25% Hank’s solution, 25% heat-inactivated horse
serum, 200 mM L-glutamine and 5,75 mg/ml glucose) [13].
Infection of retrovirus was done by exposing the concentrated
virus solution to the explant for initial two days, as described
previously  [14].  Cells  were  then  fixed  with  4%
paraformaldehyde (PFA) and frozen sectioned. For neurite
extension assay, monolayer culture of retina was conducted.
Retinal explants were prepared from E17 retinas and infected
with retroviruses. After three days in culture, the cells were
dissociated by treatment with 0.25% trypsin, and replated on
eight-well chamber slides (BD Falcon, Bedford, MA) that
were  coated  with  ornithine  (Sigma,  St.  Louis,  MO)  and
fibronrctin (Sigma). The cells were cultured for an additional
11  days  in  Dulbecco’s  modified  Eagle’s  medium/F-12
medium (Gibco BRL) that was supplemented with 1% fetal
bovine serum (JRH Biosciences, Lenexa, KS) and 1% N2
(Gibco). Cells were fixed with 4% PFA and immunostained
anti-green fluorescent protein (GFP; Clontech Laboratories,
Palo Alto, CA) and anti-glutamine synthetase (GS; Chemicon,
Temecula,  CA)  antibodies.  The  neurite  lengths  of  GFP-
positive  and  GS-negative  cells  were  examined  using
Axioplan2 fluorescent microscopy (Carl Zeiss, Oberkochen,
Germany). Then, neurite lengths of the cells were measured
from randomly taken images using AxioVision 4.6 software
(Carl Zeiss, Oberkochen, Germany) and Adobe Photoshop
Elements  2  (Adobe  Systems,  San.  Jose,  CA).  For
reaggregation culture, retroviruses were infected into retinal
explant cultures prepared from E17.5 retina. After overnight
culture, cell were dissociated by treatment with 0.25% trypsin
and used as donor cells. They were then mixed with three
times number of dissociated retinal cells that had been isolated
from the same brood and cultured overnight without virus
infection. Then, the aggregates were cultured for eight days,
and neurite extension was evaluated after immunostaining
with anti-GFP antibody.
Immunohistochemistry and antibodies:
Immunohistochemistry of retinal explants was performed as
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1624previously described [4,13]. Briefly, frozen-sections of retinal
explant were pre-incubated in a blocking solution containing
2% bovine serum albumin and incubated with the appropriate
primary antibody solutions. The primary antibodies and their
concentration  in  reaction  solution  used  were  as  follows:
1:5,000  dilution  anti-GFP  polyclonal  antibody  (Clontech
Laboratories), 1:1,000 anti-M6a (clone 321; MBL, Nagoya,
Japan), 1:100 anti-Rho4D2 (kindly provided by Dr. R. S.
Molday,  The  University  of  British  Columbia,  Vancouver,
Canada),  1:1,000  GS  (Chemicon),  1:500  anti-Hu  C/D
(Molecular  Probes,  Inc.,  Eugene,  OR),  1:100  anti-protein
kinase C (PKC; Oncogene Research Product, Boston, MA),
and  1:100  anti-Ki67  (BD  Biosciences)  monoclonal
antibodies. The primary antibodies were visualized by using
appropriate second antibodies conjugated with 1:1,000 Alexa
Fluor 488 or 546. All samples were sealed using VectaShield
mounting  media  (Vector  Laboratories,  Burlingame,  CA)
containing DAPI for nuclear staining.
BrdU  labeling  and  detection:  Three  days  after  retrovirus
infection,  retinal  explants  were  incubated  with  5  μM
bromodeoxyuridine  (BrdU)  for  24  h  before  they  were
harvested  and  fixed  with  4%  PFA.  The  samples  were
embedded in optimal cutting temperature (OCT) compound
and frozen-sectioned. The sections were treated with 1 U/μl
of  DNase  (Takara)  in  PBS  for  1  h  at  37  °C,  and  the
incorporated BrdU was visualized immunohistochemically
using  an  anti-BrdU  monoclonal  antibody  (Roche,
Indianapolis, IN) and the appropriate secondary antibodies.
RESULTS
M6a is expressed in the neuronal processes of the mouse
retina: To obtain comprehensive expression profiles of the
membrane proteins of embryonic and adult mouse retinas, we
analyzed  the  membrane  fractions  for  total  proteins  using
shotgun analysis on a nanoflow LC-MS/MS system [5]. With
this approach, we detected M6a in samples prepared from
embryonic retinas, but not in samples from adult retinas [5].
M6a is known to be widely expressed in brain [8], whereas its
detailed expression in the neural retinas of mammals has not
been reported. We examined the expression of M6a mRNA
over time, using semiquantitative RT–PCR (Figure 1A). M6a
was expressed in E14 mouse retinas, and expression continued
after birth with a slight decrease in the intensities of the bands
between P12 and P15. Finally, a weak band was observed in
the adult retina samples. We used immunohistochemistry to
investigate the spatial and temporal expression patterns of
M6a in mouse retina sections from various developmental
stages.
In the E14 retina, M6a was mainly and strongly expressed
in the NFL, which consists of the axons of ganglion cells, but
was  not  observed  in  the  neuroblastic  layer  (NBL),  which
consists of proliferating retinal progenitor cells (Figure 1B).
However, in P1 (Figure 1B,C) and P5 (data not shown) retinas,
strong expression of M6a was confined to the IPL and also in
NFL, which consists of innermost region, but not in ganglion
cell layer (GCL). At P10 (data not shown) and in the adult
retina, strong expression of M6a was detected in the IPL, and
weak signals were observed in NFL, OPL, and inner nuclear
layer (INL; Figure 1D).
M6a protein colocalizes with synaptic markers of postmitotic
cells: The βIII tubulin protein is expressed at early stages by
differentiated neurons, including ganglion and amacrine cells
and by most retinal neurons up to P7 [15]. Double staining of
retinal cells with anti-βIII tubulin and anti-M6a antibodies
revealed that most cells were double-positive at these stages,
which indicates that M6a is expressed on postmitotic mature
neurons (Figure 1C). These results are comparable with a
previous  report  that  immunolabeling  with  anti-M6a
antibodies was evident throughout the CNS of the embryonic
mouse, but was absent from the zones of cell proliferation
adjacent to the ventricles [8]. Not only for neurons, but M6a
was also weakly expressed in processes of Müller glia cells,
which are evident from the co-expression of M6a with Müller
glia marker, glutamine synthetase (Figure 1D).
Since  previous  reports  have  located  M6a
immunoreactivity in the synapses of the rat cerebellum and in
the axon terminals of the rat cerebellar molecular layer [16],
we examined the coexpression of M6a and the presynaptic
marker, synaptophysin, by immunostaining with both anti-
M6a and antisynaptophysin antibodies (Figure 1E). We found
that M6a expression colocalized with that of synaptophysin
from the embryonic to adult stages (Figure 1E).
M6a overexpression does not affect cell fate and subretinal
localization of retinal precursors: To examine the biologic
significance of M6a for retinal development, we investigated
the effects of ectopically expressed M6a in a mouse retinal
explant  culture  prepared  from  E17,  which  provides  an
excellent  model  to  monitor  retinal  differentiation  in  vitro
[13]. By E17, ganglion cells and a few other cell types have
begun to differentiate, and after two weeks in culture, all of
the retinal subpopulations have differentiated normally. The
mouse retinal explant prepared from E17 was infected with
retroviruses that encode either M6a-IRES-EGFP or IRES-
EGFP  (control)  and  cultured  for  two  weeks.  Since  the
retrovirus infects only mitotic cells, retinal precursor cells
were assumed to be the major targets of gene transfer. We
examined the subretinal localization of virus-infected cells.
The number of M6a-EGFP-expressing cells was lower in the
ONL and slightly higher in the INL than that of control EGFP-
expressing  retinal  cells,  but  both  differences  were  not
statistically significant (Figure 2A). We then examined the
differentiation  of  virus-infected  cells  by  immunostaining
frozen  sections  with  antibodies  against  various  marker
proteins  for  retinal  cell  subpopulations  (Figure  2B).  The
antibodies used were antirhodopsin for rod photoreceptors,
anti-HuC/D for retinal ganglion cells, and amacrine cells, anti-
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1625PKC  for  bipolar  cells,  and  anti-GS  for  Müller  glia.  The
percentage of rhodopsin positive M6a-overexpressing cells
was not significantly, but few times higher than that of control
cells (Figure 2B). The other retinal cell populations were not
affected by M6a overexpression, which suggests that M6a
does not play a role in retinal differentiation.
M6a does not affect retinal precursor cell proliferation: We
next examined whether M6a affects the proliferation of retinal
cells by measuring BrdU incorporation. Retrovirus-mediated
gene transfer into retinal explants prepared from E15.5 or
E17.5 was conducted, and proliferating cells were labeled
with 5 μM BrdU for the final 24 h of four days of culture. In
all cases BrdU incorporation was slightly higher in the M6a-
expressing cells than in control cells. Despite this general
trend, statistical analysis revealed that the differences were
not statistically significant (Figure 2C). Immunostaining the
Figure 1. Expression of M6a in mouse retinas from various developmental stages. A: Semiquantitative RT–PCR for M6a using total RNA
extracted from mouse retinas at various developmental stages. Glyceraldehyde-3-phosphate dehydrogenase (G3PDH) was used as the control.
B-E: Immunostaining of M6a in frozen sections of mouse retina from various developmental stages. Coimmunostaining was performed with
anti-M6a and anti-βIII-tubulin (C), anti-glutamine synthetase (D), or antisynaptophysin (E) antibodies. The right two columns are magnified
figure of the square area indicated by broken lines in left two columns B. The scale bar represents 100 μm. The following abbreviations are
used in this figure: inner plexiform layer (IPL); outer plexiform layer (OPL); ganglion cell layer (GCL); neuroblastic layer (NBL); inner
nuclear layer (INL); outer nuclear layer (ONL); retinal pigment epithelium (RPE).
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1626sections  with  the  antiproliferation  antigen,  Ki67  antibody
[17], produced slightly more Ki67-positive cells among the
M6a-expressing cells than the control cells. These differences
were not considered statistically significant, thus confirming
the BrdU results (Figure 2D). Taken together, these results
suggested a minor trend of increased proliferation associated
with M6a but demonstrated that M6a does not regulate retinal
cell proliferation significantly.
To  confirm  the  proliferation  results,  we  performed  a
clonal assay [4] to test the proliferation capabilities of the
virus-transfected M6a cells (data not shown). The colony sizes
showed no significant differences between the control and
M6a-transfected retinal cells.
M6a overexpression promotes neurite outgrowth in retina:
Since M6a has been implicated in neurite extension in brain,
we investigated whether M6a was also involved in neurite
extension in the retina, using monolayer cultures of retinas
Figure 2. Effects of forced expression of
M6a  on  retinal  differentiation  and
proliferation. A: Sublayer distributions
of  virus-transduced  enhanced  green
fluorescent  protein  (EGFP)-positive
cells in retinal explants. Retinal explants
were infected with retorovirus particles
that encode M6a and EGFP. After 14
days, the explants were harvested and
frozen-sections  prepared.
Immunostaining  was  performed  using
an  anti-EGFP  antibody.  The
percentages of cells in each sublayer are
shown.  More  than  200  cells  were
counted  for  each  sample,  and  the
standard deviation (SD) was calculated
from  three  independent  experiments.
B: Differentiation of virus-infected cells
examined  by  immunostaining  to
identify  subpopulations  within  the
retina.  The  percentages  of  marker-
positive  cells  in  the  EGFP-positive
population  are  shown.  Rhodopsin  for
rod, HuC/HuD for amacrine, glutamine
synthetase for Müller glia, and protein
kinase  C  for  bipolar  were  used  as
markers.  More  than  100  cells  were
examined  for  each  sample,  and  the
average value from three independent
experiments  is  shown  with  the  SD.
C,D:  Proliferation  of  M6a-expressing
retinal cells was examined by measuring
incorporation  of  bromodeoxyuridine
(BrdU;  C)  or  expression  of  the  Ki67
antigen (D). BrdU was present for the
final  24  h  of  four  days  of  culture  of
retinal  explants,  and  frozen  sections
were  immunostained  using  antibodies
against BrdU. The same samples were
immunostained  with  the  anti-
Ki67antibody.  The  percentage  of
positive cells with SD are shown. Listed
below each panel is the stage when each
retinal  explant  was  prepared  and  its
culture  period.  The  following
abbreviations are in effect: outer nuclear
layer (ONL); inner nuclear layer (INL);
ganglion cell layer (GCL).
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1627infected with retroviruses that encode control EGFP or M6a-
IRES-EGFP. Neurite extension in monolayer cultures was
examined  by  measuring  the  length  of  neurites  from
photographs  taken  under  a  fluorescence  microscope.  To
distinguish neural cells from glial cells, we stained the retinal
cells with antibody against GS, which is a glial cell marker,
and  evaluated  the  neurite  lengths  of  the  GS-negative  and
EGFP-positive cells. In both the control and M6a-expressing
samples, approximately 60% of the cells extended neurites by
0–10 μm of neurite. However, when we compared the cell
population  distribution  categorized  by  neurite  length,  we
discovered  that  M6a-expressing  cells  extended  longer
neurites than did control virus-infected cells (Figure 3A). The
average neurite lengths were greater than 10 μm for the M6a-
overexpressing cells (39.2 μm) and control cells (25.5 μm;
Figure 3B). We next confirmed these results with a different
method of culture. We prepared reaggregation cultures by
mixing dissociated virus-infected retinal explants prepared
from E17.5 and dissociated retinal cells isolated from the same
brood. Eight days later, percentage of M6a-overexpressing
retinal cells bearing neurite over 30 μm length was about
twice-times higher than that of control EGFP expressing cells
(Figure  3C,D).  This  indicates  that  M6a  plays  a  role  in
promoting the neurite extension during retinal development.
DISCUSSION
M6a protein is targeted to the neuron processes of the murine
retina: In the present study, strong expression of M6a was
detected in the ganglion cell axons and processes of cells
located in the INL of the immature murine retina. A previous
report on in situ hybridization of M6a in the Xenopus eye
demonstrated expression of M6a mRNA in the INL and GCL,
and weak expression in the ONL [18], which suggests that the
expression of M6a in the retina is conserved in vertebrates.
In mouse hippocampal tissues, M6a mRNA has been
found to be expressed in granule cells of the dentate gyrus and
pyramidal neurons in CA1 and CA3; immunoreactivity for
M6a  was  concentrated  in  the  regions  of  relatively  dense
synaptic contact [11]. Similar results have been obtained for
the rat [16]. This implies that the translated M6a protein is
targeted to processes distal to the somata. The expression of
M6a paralleled that of the presynaptic protein, synaptophysin,
in  the  mouse  retina,  suggesting  that  the  subcellular
distribution of M6a is the same in the brain and retina. It has
Figure 3. Effects of forced expression of
M6a on retinal neurite extension. A,B:
Neurite  extension  of  virus-transduced
enhanced  green  fluorescent  protein
(EGFP)-positive  cells  in  retinal
monolayer  cultures.  Retinal  explants
were infected with retorovirus particles
that  encode  M6a  and  EGFP,  and  the
cells were dissociated and subjected to
monolayer culturing. After 11 days of
culture, the cultures were harvested and
stained with anti-GFP antibody. Neurite
length was examined by measuring the
EGFP-positive neurites on photographs
taken under a fluorescence microscope.
The length distribution percentages for
the neurites are shown in A. The average
lengths of neurites longer than 10 μm are
shown in B. More than 100 cells were
counted for each sample, and essentially
the same results were obtained in three
independent experiments. C,D: Neurite
extension  of  virus-transduced  EGFP-
positive  cells  in  retinal  reaggregation
cultures. Morphology of the M6a-EGFP
virus-transfected  retinal  cells  in
reaggregation  culture  (C).  The
percentage  of  cells  with  neurite
extensions of 30-100 μm or 100-200 μm
in the M6a and control EGFP expressed
retinal cells (D). Asterisk is p<0.05 by
the Student's t-test.
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1628been  established  that  synapse  formation  by  dissociated
neurons  in  culture  strongly  correlates  with  focal
accumulations  of  structures  that  can  be  labeled  with
antibodies  against  synaptic  vesicle  proteins,  such  as
synaptophysin [19]. Therefore, our results indicate a possible
role for M6a in the formation of synapses in neural retinas.
M6a does not affect retinal progenitor cell differentiation and
proliferation:  We  found  that  cell  fate  and  subretinal
localization of retinal progenitor cells were not affected by
M6a overexpression. To date, there has been no report on the
promotion of proliferation by M6a. On the other hand, it has
been reported that the addition of anti-M6a antibody decreases
the survival of dissociated neurons in culture and inhibits the
extension of neurites in cultured cerebellar explants [9]. M6a
belongs  to  the  proteolipid  protein  (PLP)/DM20  family  of
myelin  proteins.  PLPs  play  a  pivotal  role  in  early
oligodendrocyte  differentiation  and  survival  [20].  PLP
members have been observed to form a complex with integrins
and  may  participate  in  integrin  receptor  signaling  in
oligodendrocytes [21]. Given the high degree of homology
between M6a and PLP, it is possible that this transmembrane
protein is also related to integrin signaling. Our preliminary
results  from  examining  integrin  family  proteins  in  the
developing retina reveal the expression of integrin αv in the
embryonic mouse retina (unpublished results) which suggests
that M6a plays role in retinal development through interaction
with integrins to mediate signals for retinal development.
M6a promotes neurite outgrowth in the retina: In the present
study, we observed promotion of retinal neurite extension by
M6a.  This  protein  has  been  reported  to  enhance  neurite
extension in rat pheochromocytoma PC12 cells and to induce
an increase in the intracellular Ca2+ concentration of PC12
cells [10]. The anti-M6 antibody efficiently interfered with
Ca2+ influx, which suggests that M6a acts as a Ca2+ channel
blocker in PC12 cells. As a second messenger, Ca2+ has been
shown  to  participate  in  neurite  extension,  filopodium  and
spine  activity,  and  neuronal  differentiation  [22].  M6a
possesses two PKC phosphorylation sites. Treatment of PC12
cells with a PKC inhibitor eliminates the ability of M6a to
promote nerve growth factor-primed neurite extension [10].
Thus  the  putative  phosphorylation  sites  in  the  cytosolic
domains may facilitate M6a regulation and may be relevant
for intracellular signaling. Therefore, the promotion of neurite
extension by M6a in retinal cells seen in the present study is
possibly associated with Ca2+ influx, and phosphorylation of
PKC may remove this function. Future studies will focus on
this hypothesis.
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